Identification of Key Immune-Related Genes in the Treatment of Heart Failure After Myocardial Infarction with Empagliflozin Based on RNA-Seq.

Pei ZhangTian-Yu WangZi-Yue LuoJun-Can DingQiang Yang Peng-Fei Hu

Published in: Journal of inflammation research (2023)

Col17a1 and Gria4 are key immune-related genes of empagliflozin in the treatment of heart failure after myocardial infarction. This study provides a scientific basis for elucidating the mechanism of action of empagliflozin in treating heart failure after myocardial infarction.

Keyphrases

heart failure
rna seq
single cell
left ventricular
combination therapy
replacement therapy
smoking cessation